“Good Governance in Medicine” BUDIONO SANTOSO

Definition (1) Corruption Oxford dictionary “Corruption” is

deprived, wicked, influenced by bribery or fraudulent activity.

http://www.vocabulary.com/dictionary ◦ “Lack of integrity or honesty (especially susceptibility to bribery); use of a position of trust for dishonest gain” ◦ “Inducement (as of a public official) by improper means (as bribery) to violate duty (as by committing a felony)” World Bank & UNDP ◦ “Corruption is most commonly defined as the misuse or the abuse of public office for private gain (World Bank, 1997, UNDP, 1999)”.

Definition (2) Ethics & medical ethics www.merriam-webster.com/dictionary/ethic “the discipline dealing with what is good and bad and with moral duty and obligation”

http://www.oxforddictionaries.com/definition/english/ethics ◦ Moral principles that govern a person’s behaviour or the conducting of an activity: n

http://www.oxforddictionaries.com/definition/english/medical-ethics ◦ Moral principles that govern the practice of medicine: here medical ethics are unambiguous: the mother comes first medical ethics is part of the core of medical education

Definition (3) Good governance & transparency World Bank ◦ Governance is the process – by which authority is conferred on rulers, by which they make the rules, and by which those rules are enforced and modified”. ◦ Good governance is defined in terms of the mechanisms thought to be needed to promote it. For example, in various places, good governance has been associated with democracy and good civil rights, with transparency, with the rule of law, and with efficient public services.

Transparency Transparency, as used in science, engineering, business, the humanities and in other social contexts, implies openness, communication, and accountability. Transparency is operating in such a way that it is easy for others to see what actions are performed. It has been defined simply as "the perceived quality of intentionally shared information from a sender".

Why Good governance in medicines ? - Medicine sector is prone to unethical practices R&D and clinical trials

R&D priorities

Patent

Unlawful appropriation royalties

Counterfeit/ substandard Tax evasion Conflict of interest

Manufacturing Registration Pricing

Cartels

Selection Unethical donations

Collusion

Pressure

Procurement & import

Overinvoicing

Thefts

Distribution Inspection

Falsification safety/ efficacy data

Bribery

Prescription Dispensing

State Capture

Pharmacovigilance Unethical promotion

Promotion

Why is the pharmaceutical system vulnerable to corruption? High market value Highly regulated ◦ Poorly defined and documented processes ◦ Lack of check and balances ◦ Too many institutional checks Information imbalance between the various players to ◦ Make independent assessments ◦ Informed judgments Conflict of interest Inappropriate incentive structures

Corruption identified as the single greatest obstacle to economic and social development US$ 3 trillion spent on health services annually Global pharmaceutical market: > US$ 600b 10 to 25% procurement spending lost into corruption (including health sector) Some countries report that 2/3 medicines supplies lost through corruption and fraud in hospitals Low quality trials exaggerate the benefits of treatment by an average of 34% Bribery of high officials in regulatory authorities has led to unsafe medicines circulating on the market resulting in deaths

Unethical practices can have significant impact on health systems Health impact ◦

Unsafe medicines on the market



Lack EM in health facilities



Irrational use of medicines

Economical impact ◦



Pharma. expenditure low-income countries: ◦

10-40% of public health budget



20-50% of total health care expenditures

Poor most affected  inequalities

Image and trust impact ◦

Reduces government capacity



Reduces credibility of health profession



Erodes public trust

Pendekatan dengan latar belakang yang berbeda terhadap penyimpangan etika & korupsi Inefficient System

Dysfunctional mentality • Educational • Ethical • Behavioral approaches



• •

Combined individuals and system approaches

Medicines Registration Medicines selection, supply, Regulatory and legal system

• Pencegahan pelanggaran etika, gratifikasi dan korupsi serta • Peningkatkan keterbukaan (transparency) • Tata kelola yang baik (good governance) Tidak bisa hanya dengan satu pendekatan saja - Pendekatan sosio kultural - Pendekatan etika - Pendekatan perilaku (bevioural approach) - Pendekatan hukum - Pendekatan sistem

WHO WPRO Pilot Project on Promoting Good and Ethical Practices in Medicines Registration and Procurement ( 2002-2004) (Regional Program) Conceptual framework Self assessment with unified instruments and indicators Feed back to all stakeholders Recommendations for remedial action Follow up within the system ◦ Development of coordinated remedial program ◦ Implementation of the remedial program Countries : Laos, Malaysia, Mongolia, Philippines, Indonesia & Thailand

WHO Good Governance for Medicines Programme – Global Program Promotion of ethical practices and development and use of anti corruption measures in the pharmaceutical sector (2004 - ) Goal ◦ To increase transparency in pharmaceutical sector systems through the application of transparent and accountable administrative procedures and the promotion of ethical practices among health professionals. Specific objectives ◦ To increase the awareness of all stakeholders on the need for transparency in the pharmaceutical sector. ◦ To increase transparency and accountability in medicines regulatory systems and supply management systems. ◦ To promote individual and institutional integrity in the pharmaceutical sector ◦ To institutionalise good governance in pharmaceutical system by building build national capacity and leadership.

Complementary WHO GGM strategies Disciplines based approach (top down) ◦ “Based on legislative reforms, and establishing the laws, administrative structure and processes that are required for transparent medicines regulation, procurement and supply system”. Values based approach (bottom up) ◦ “ Promote institutional integrity through ethical principles and motivating ethical conduct by public servant”

Phase I National transparency assessment Assesses level of transparency and

Elements evaluated:

vulnerability to corruption of the

––National regulations and official

existing regulatory, procurement and

policy documents.

supply systems

––Written procedures and decision making

––Regulation: registration, licensing,

processes.

inspection, promotion, clinical trials;

––Committees, criteria for membership

––Supply: selection, procurement,

and conflict of interest policies.

distribution.

––Appeals mechanisms and other monitoring systems

Follow up – after the assessment PHASE II : DEVELOPMENT OF A NATIONAL GOOD GOVERNANCE IN MEDICINES PROGRAM

PHASE III : IMPLEMENTATION OF GGM PROGRAM

1.

Ethical infrastructures

1.

Secure government commitment

2.

Management of interest

2.

3.

System efficiency

Participation and support from relevant stakeholders

4.

System transparency

3.

Institutionalization

4.

Dissemination

5.

Training, advocacy & education

6.

Monitoring and evaluation

5. 6.

Whistle blower mechanism etc

Targets of the intervention National medicines regulatory authority

National medicines procurement agency

Countries participating in WHO GGM program 2004 - 2012

Lessons learnt – weaknesses and vulnerability Regulation and control of medicines promotion was most frequently identified as vulnerable to corruption. Wide spread lack of public access to information about the pharmaceutical sector ( medicines pricing, information on quality and suppliers etc. ). Lack of formal written criteria to guide the selection of members of key committees such as selection committee is a common challenge, Medicines registration committees frequently have a weak policy base and adequate operational procedures, Conflict of interest policies are lacking in many countries, and may be poorly implemented in those they do exist WHO 2013 – Evaluation of the Good Governance for Medicines Program, 2004 – 2012. Brief summary of findings. WHO/EMP/MPC/2013.1

Factors facilitating success of the implementation of WHO GGM program Levels of priority and support in countries Engagement with other Ministries responsible to tackle corruption & cross sector advocacy for good governance. Momentum of support from higher political leader, especially head of states, The need of senior and technically knowledgeable figure in the GGM group, Support from WHO country and regional levels to facilitate process. WHO 2013 – Evaluation of the Good Governance for Medicines Program, 2004 – 2012. Brief summary of findings. WHO/EMP/MPC/2013.1

Principal findings and conclusions of program evaluation 2004 - 2012 i. Concrete outcomes improvements in medicines procurement & regulatory practices ii. Increased awareness about the impact of weak governance, including unethical behavior, on access to medicines iii. Increased awareness of the value of transparency among key national stakeholders. iv. Increased international awareness of the value of transparency and good governance for medicines. v. Significant value for money for the program. vi. The three-phase methodology has proved to be of value to participating countries. The Phase I assessment tool, in particular, is facilitative, focused and easy to use. It has proven effective in engaging all major national stakeholders in the GGM process and acts as a means to increase awareness, stimulate dialogue and identify shortfalls. The fact that it is not perceived as an audit is regarded as helpful.

Bagaimana mencegah dan mengurangi gratifikasi pada profesi medik ? & Meningkatkan tatakelola dan transparansi (good governance & transparency)?

Siapa yang menjadi target intervensi ? Calon professional ◦ Institusi pendidikan kedokteran ◦ Dosen ◦ Calon dokter

Profesional/praktisi ◦ Organisasi profesi ◦ Dokter dokter yang berpraktek

Industri/pemasok obat

Asosiasi industri Industri Konsumen/masyarakat Lembaga swadaya masyarakat Masyarakat umum

Usulan Program – lembaga pendidikan dokter 1. Jejaring antar lembaga pendidikan & dosen 2. Kesepakatan mengenai tujuan, isi kurikulum dan cara pendidikan untuk calon dokter ◦ ◦ ◦

Menanamkan pemahaman dan pengetahuan mengenai dampak gratifikasi dan perbuatan tdk etis dalam pengobatan,, Memberikan motivasi untuk melakukan praktek pengobatan sesuai etika, Menanamkan sikap kritis, manusiawi dan empati.

3.

Tukar pengalaman dan informasi secara berkala antar lembaga pendidikan dan dosen,

4.

Monitoring dan evaluasi pelaksanaan di masing2 lembaga pendidikan.

Usulan untuk organisasi profesi Membuat program peningkatan keterbukaan dalam praktek dokter Penyuluhan bagi para praktisi Kriteria keterbukaan untuk kegiatan promosi obat dan kerja sama dengan industri (komponen2 yang perlu dilakukan oleh praktisi) Declaration of interest di tempat praktek Patient informed decision

Partisipasi sukarela Peserta yang berpartisipasi dan melaksanakan komponen yang perlu dilakukan memperoleh kredit untuk re-registrasi

Uji coba

Usulan untuk lembaga swadaya dan industri LEMBAGA SWADAYA

INDUSTRI

Penyuluhan dan pemberdayaan pasien

Ethical criteria on pharmaceutical promotion

Hak atas informasi

Terima kasih

Budiono Santoso - Good Governance in Medicine.pdf

Page 2 of 27. Definition. (1) Corruption. Oxford dictionary. “Corruption” is deprived, wicked, influenced by bribery or fraudulent activity.

958KB Sizes 0 Downloads 143 Views

Recommend Documents

Good Governance Laws.pdf
the 2016 Acquisition for 1Q 2017. Whoops! There was a problem loading this page. Retrying... Whoops! There was a problem loading this page. Retrying... Good Governance Laws.pdf. Good Governance Laws.pdf. Open. Extract. Open with. Sign In. Main menu.

Good governance in health care the Karnataka experience.pdf ...
benefi ciaries, service providers, local leaders, women's ... Section_2.pdf (accessed Nov 18, 2010). ... Global Fund to Fight AIDS, Tuberculosis and Malaria.8.

Promoting Good Governance through CSO - Legislatores Linkeage ...
Promoting Good Governance through CSO - Legislatores Linkeage.pdf. Promoting Good Governance through CSO - Legislatores Linkeage.pdf. Open. Extract.

good-corporate-governance-tata-kelola-perusahaan.pdf
good-corporate-governance-tata-kelola-perusahaan.pdf. good-corporate-governance-tata-kelola-perusahaan.pdf. Open. Extract. Open with. Sign In. Main menu.

The Antinomies of 'good governance': independence ...
the development banks and multinational companies (in Dixon 1998). .... was described as the first form of formal international 'governance', in the modern ...... Accounting Office, Report to the Chairman, Committee on Foreign Relations, U.S..

Boosting Tunisia's Economic Growth through Good Governance - IACE
Sep 13, 2017 - half-day event, entitled Boosting Tunisia's Economic Growth Through Good Governance: Examples from Around the World, Mr. Fukuyama will share his wealth of knowledge from around the world about how good governance and strong institution

The Antinomies of 'good governance': independence ... - Tim Anderson
elements within Australian programs of good governance and regional ...... Anderson, Tim (2006c) The collapse of Australia's Pacific intervention, Online Opinion, ... Ben, Waita and Peter Larmour (Eds) (1979) Land in Solomon Islands, Institute ...

Good Governance - The Supreme Mantra For Multi ... -
Mysore. Mysore. Cordially invite you for. Three Days Joint Workshop on. “Good Governance - The Supreme Mantra. For Multi-Skilled Professional”. On 20th, 21st ...

Did Good Cajas Extend Bad Loans? Governance ...
Nov 3, 2009 - Specifically, those Cajas led by Chairmen without graduate studies .... different accounting standards used by Cajas accountants versus the ... In the case of savings banks it is conceivable that there is some degree of conflict.

The Exigencies of Our Time Good Global Governance ...
Mar 2, 2003 - The proposed model will be examined through the course of the .... organizations such as the United Nations cannot effectively manage global processes under ...... services in public-administration in post-conflict situations.

Did Good Cajas Extend Bad Loans? Governance ...
Nov 3, 2009 - The question we study in this paper is what accounts for such heterogeneity. In ... information from the bylaws of the different savings banks.

Model of CSO Participation in Research Governance
Cross-analysis existing network of cooperation / Reliability of partners . ...... improvement, CSO benefits, Social interests/gaining legitimacy, policy outcomes, ...

Model of CSO Participation in Research Governance
Main contributors. Quality assurance. Name. Review Chair. Stephen Barnett ... This analytical model illustrates the interrelation between all ... With regards to the social impact of research, the timing of CSO participation and the CSOs' influence .

Governance in India - M. Laxmikanth.pdf
Governance in India - M. Laxmikanth.pdf - Google Drivehttps://drive.google.com/file/d/0B9xDFaC4cXl_Y2dhbHdZSndsUkE/editMissing: mobile ‎device ‎manager

International Conference LOCAL GOVERNANCE IN ...
democracy. This comes from the observations that the country has a heavy burden of apartheid social backlogs as an emerging economy, even though it has a progressive constitution. There is pressure to deliver on living standards, education, health an

Call for Papers_CORRUPTION AND GOVERNANCE IN NORTH ...
Call for Papers_CORRUPTION AND GOVERNANCE IN NORTH EAST INDIA.pdf. Call for Papers_CORRUPTION AND GOVERNANCE IN NORTH EAST INDIA.